The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis
- PMID: 34087553
- PMCID: PMC8137345
- DOI: 10.1016/j.trre.2021.100628
The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis
Abstract
Background: The effect of solid organ transplantation (SOT) on the severity and mortality of coronavirus disease 2019 (COVID-19) remained controversial. There is still no consensus on whether solid organ transplantation (SOT) recipients with COVID-19 are at greater risk of developing severe or fatal COVID-19. Therefore, we conducted a systematic review and meta-analysis to investigate the association between SOT, severe COVID-19 illness, and mortality.
Methods: A systemically comprehensive search in Pubmed, Embase, the Cochrane Library, Web of Science, and China National Knowledge Infrastructure was performed for relevant studies and articles. Consequently, we pooled the odds ratio (OR) from individual studies and performed heterogeneity, quality assessment and subgroup/sensitivity analysis.
Results: A total number of 15 articles with 265,839 participants were included in this study. Among the total number of participants, 1485 were SOT recipients. The meta-analysis results showed that transplant patients with COVID-19 were remarkably associated with a higher risk of intensive care unit admission than non-transplant patients (OR = 1.57, 95%CI: 1.07 to 2.31, P = 0.02). On the other hand, there were no statistically significant differences between SOT recipients and non-SOT recipients in mechanical ventilation need (OR = 1.55, 95%CI: 0.98 to 2.44, P = 0.06). In addition, we found that SOT recipients with COVID-19 had 1.40-fold increased odds of mortality than non-SOT recipients (OR = 1.40, 95%CI: 1.10 to 1.79, P = 0.007). Moreover, pooled analysis of adjusted results revealed that SOT recipients had a greater risk of mortality compared with non-SOT patients (HR = 1.54, 95%CI: 1.03 to 2.32, P = 0.037).
Limitations: The main limitations in our study are attributed to the relatively small sample size, short follow-up period, and the fact that most of the studies included were retrospective in design.
Conclusions: The results of this study indicate that SOT recipients with COVID-19 had a more significant risk of COVID-19 severity and mortality than the general population.
Keywords: COVID-19; Meta-analysis; Mortality; Severe; Solid organ transplantation.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
None.
Figures



Similar articles
-
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients.PLoS One. 2021 Mar 3;16(3):e0247251. doi: 10.1371/journal.pone.0247251. eCollection 2021. PLoS One. 2021. PMID: 33657157 Free PMC article.
-
Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis.J Infect Public Health. 2022 Mar;15(3):365-372. doi: 10.1016/j.jiph.2022.02.002. Epub 2022 Feb 19. J Infect Public Health. 2022. PMID: 35193818 Free PMC article.
-
Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19.Clin Transplant. 2022 Jan;36(1):e14492. doi: 10.1111/ctr.14492. Epub 2021 Oct 1. Clin Transplant. 2022. PMID: 34558116 Free PMC article.
-
An overview of COVID-19 in solid organ transplantation.Clin Microbiol Infect. 2022 Jun;28(6):779-784. doi: 10.1016/j.cmi.2022.02.005. Epub 2022 Feb 18. Clin Microbiol Infect. 2022. PMID: 35189336 Free PMC article. Review.
-
COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study.Transplantation. 2021 Jan 1;105(1):128-137. doi: 10.1097/TP.0000000000003447. Transplantation. 2021. PMID: 32890139 Free PMC article.
Cited by
-
Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group.Nephrol Dial Transplant. 2022 Sep 22;37(10):1824-1829. doi: 10.1093/ndt/gfac203. Nephrol Dial Transplant. 2022. PMID: 35746885 Free PMC article.
-
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement.Sci Rep. 2024 Jul 23;14(1):16985. doi: 10.1038/s41598-024-68013-6. Sci Rep. 2024. PMID: 39044026 Free PMC article.
-
Incidence and severity of SARS-CoV-2 infection in lung transplant recipients in the Omicron era.JHLT Open. 2023 Sep 20;1:100004. doi: 10.1016/j.jhlto.2023.100004. eCollection 2023 Oct. JHLT Open. 2023. PMID: 40144583 Free PMC article.
-
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.Am J Transplant. 2022 Aug;22(8):2083-2088. doi: 10.1111/ajt.17027. Epub 2022 Mar 21. Am J Transplant. 2022. PMID: 35278260 Free PMC article.
-
Efficacy and Safety of Remdesivir in Adult Solid Organ Transplant Recipients: A Scoping Review.Pharmaceuticals (Basel). 2024 Jun 11;17(6):765. doi: 10.3390/ph17060765. Pharmaceuticals (Basel). 2024. PMID: 38931432 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical